{
  "version": "1.2.0",
  "chapters": [
    {
      "title": "We Spend Less on Healthcare? Setting Up the Policy Debate\r",
      "startTime": 42,
      "endTime": 80
    },
    {
      "title": "Drug Price Negotiation Case Study: Eliquis & the 56% ‘Discount’\r",
      "startTime": 80,
      "endTime": 359
    },
    {
      "title": "Competition Beats Negotiation: Patent Cliffs, Incentives, and Innovation Tradeoffs\r",
      "startTime": 359,
      "endTime": 874
    },
    {
      "title": "Surprises Act Explained: Ending Balance Billing with IDR Arbitration\r",
      "startTime": 874,
      "endTime": 1011
    },
    {
      "title": "Sounds the Alarm: IDR ‘Gaming’ and Rising ACA Medical Costs\r",
      "startTime": 1011,
      "endTime": 1283
    },
    {
      "title": "ACCESS Model: Lower Reimbursement, More Competition, and Public Quality Data\r",
      "startTime": 1283,
      "endTime": 1702
    },
    {
      "title": "Spotlight: GRAIL’s Cancer Screening Test, Trial Miss, and Reimbursement Risk\r",
      "startTime": 1702,
      "endTime": 1883
    },
    {
      "title": "B2B Turnaround: Revenue Mix, Growth & Margins\r",
      "startTime": 1883,
      "endTime": 1985
    },
    {
      "title": "+ AI ‘Access’ Rates: Can $106/session Become $180/year?\r",
      "startTime": 1985,
      "endTime": 2176
    },
    {
      "title": "Health Systems Earnings: Divestitures, Pricing vs Volume, ‘Have-Nots’\r",
      "startTime": 2176,
      "endTime": 2358
    },
    {
      "title": "Buys Eucalyptus: International Expansion & GLP-1 Compounding Pressure\r",
      "startTime": 2358,
      "endTime": 113
    },
    {
      "title": "Investor Q&A Gets Spicy: FDA Letter, Novo Lawsuit & 42% Short Interest\r",
      "startTime": 113,
      "endTime": 2692
    },
    {
      "title": "Advantage Reality Check: Scripps Exits While Cleveland Clinic Leans In\r",
      "startTime": 2692,
      "endTime": 3081
    },
    {
      "title": "to Watch Next: Upcoming Earnings (Clover, Alignment, Agilon, GoodRx, More)\r",
      "startTime": 3081,
      "endTime": 3195
    },
    {
      "title": "Rebate Model Returns: Pharma Negotiation Wishlist & Hospital Pushback\r",
      "startTime": 3195,
      "endTime": 3414
    },
    {
      "title": "Goes Private: Home Health/Hospice Headwinds, PE Math & 2026 Take-Private Trend\r",
      "startTime": 3414,
      "endTime": 3644
    },
    {
      "title": "Tracking the Week Ahead",
      "startTime": 3644,
      "endTime": 0
    }
  ]
}